Insight into the catalytic mechanism of arginine deiminase: Functional studies on the crucial sites

Proteins: Structure, Function and Genetics

Volumn 66, Issue 3, 2007, Pages 740-750

  Wei, Yunzhou ^a   Zhou, Hao ^a   Sun, Yi ^a   He, Yingbo ^a   Luo, Yongzhang ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Arginine; Catalytic center; Crucial sites; Enzymatic activity; Mutation; Structure; Substrate induced conformational change

Indexed keywords

ARGININE; ARGININE DEIMINASE; ASPARTIC ACID; CITRULLINE; GLUTAMINE; GUANIDINE; HISTIDINE;

CATALYSIS; CELL PROLIFERATION; CIRCULAR DICHROISM; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; ENZYME ACTIVITY; ENZYME MECHANISM; FLUORESCENCE; HUMAN; HUMAN CELL; HYDROLYSIS; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; TRYPTOPHAN EMISSION FLUORESCENCE;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BINDING SITES; CATALYSIS; CIRCULAR DICHROISM; HYDROLASES; KINETICS; MODELS, MOLECULAR; MYCOPLASMA HOMINIS; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, FLUORESCENCE;

MYCOPLASMA HOMINIS;

EID: 33846250027     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21235     Document Type: Conference Paper

References (31)

1. Weickmann JL, Fahrney DE. Arginine deiminase from Mycoplasma arthritidis. Evidence for multiple forms. J Biol Chem 1977;252:2615-2620.
2. Smith DW, Ganaway RL, Fahrney DE. Arginine deiminase from Mycoplasma arthritidis. Structure-activity relationships among substrates and competitive inhibitors. J Biol Chem 1978;253:6016-6020.
3. Sugimura K, Ohno T, Kusuyama T, Azuma I. High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro. Melanoma Res 1992;2:191-196.
4. Takaku H, Takase M, Abe S, Hayashi H, Miyazaki K. In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini. Int J Cancer 1992;51:244-249.
5. Philip R, Campbell E, Wheatley DN. Arginine deprivation, growth inhibition and tumour cell death, Part 2: Enzymatic degradation of arginine in normal and malignant cell cultures. Br J Cancer 2003;88:613-623.
6. Park IS, Kang SW, Shin YJ, Chae KY, Park MO, Kim MY, Wheatley DN, Min BH. Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth. Br J Cancer 2003;89:907-914.
7. Takaku H, Matsumoto M, Misawa S, Miyazaki K. Anti-tumor activity of arginine deiminase from Mycoplasma arginini and its growth-inhibitory mechanism. Jpn J Cancer Res 1995;86:840-846.
8. Thomas JB, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA. Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor α and endotoxin. Biochem J 2002;363 (Pt 3):581-587.
9. Shen LJ, Lin WC, Beloussow K, Hosoya K, Terasaki T, Ann DK, Shen WC. Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochem Pharmacol 2003;66:1945-1952.
10. Gong H, Zolzer F, von Recklinghausen G, Havers W, Schweigerer L. Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia 2000;14:826-829.
11. Sezgin N, Torun T, Yalcin F. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Med Sci Monit 2002;8:LE44.
12. Murray-Rust J, Leiper J, McAlister M, Phelan J, Tilley S, Santa Maria J, Vallance P, McDonald N. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat Struct Biol 2001;8:679-683.
13. Choi JW, Haigh WG, Lee SP. Caveat: mycoplasma arginine deiminase masquerading as nitric oxide synthase in cell cultures. Biochim Biophys Acta 1998;1404:314-320.
14. Miyazaki K, Takaku H, Umeda M, Fujita T, Huang WD, Kimura T, Yamashita J, Horio T. Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line. Cancer Res 1990;50:4522-4527.
15. Galkin A, Kulakova L, Sarikaya E, Lim K, Howard A, Herzberg O. Structural insight into arginine degradation by arginine deiminase, an antibacterial and parasite drug target. J Biol Chem 2004;279:14001-14008.
16. Das K, Butler GH, Kwiatkowski V, Clark AD, Jr, Yadav P, Arnold E. Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism. Structure (Camb) 2004;12:657-667.
17. Lu X, Galkin A, Herzberg O, Dunaway-Mariano D. Arginine deiminase uses an active-site cysteine in nucleophilic catalysis of L-arginine hydrolysis. J Am Chem Soc 2004;126:5374-5375.
18. Galkin A, Lu X, Dunaway-Mariano D, Herzberg O. Crystal structures representing the Michaelis complex and the thiouronium reaction intermediate of Pseudomonas aeruginosa arginine deiminase. J Biol Chem 2005;280:34080-34087.
19. Das K, Butler GH, Kwiatkowski V, Clark AD, Jr, Yadav P, Arnold E. Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism. Structure 2004;12:657-667.
20. Liu M-C, Masahito Suiko, Sakakibara Y. Mutational analysis of the substrate binding/catalytic domains of human m form and p form phenol sulfotransferases. J Biol Chem 2000;275:13460-13464.
21. Dillon BJ, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Med Sci Monit 2002;8:BR248-253.
22. Gong H, Zolzer F, von Recklinghausen G, Rossler J, Breit S, Havers W, Fotsis T, Schweigerer L. Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis. Biochem Biophys Res Commun 1999;261:10-14.
23. Shirai H, Blundell TL, Mizuguchi K. A novel superfamily of enzymes that catalyze the modification of guanidino groups. Trends Biochem Sci 2001;26:465-468.
24. Schimke RT, Berlin CM, Sweeney EW, Carroll WR. The Generation of energy by the arginine dihydrolase pathway in Mycoplasma hominis 07. J Biol Chem 1966;241:2228-2236.
25. Weickmann JLMEH, Squire PG, Fahrney DE. Arginine deiminase from Mycoplasma arthritidis: properties of the enzyme from log phase cultures. J Biol Chem 1978;253:6010-6015.
26. Santoro MM, Bolen DW. Unfolding free energy changes determined by the linear extrapolation method, Part 1: Unfolding of phenylmethanesulfonyl α-chymotrypsin using different denaturants. Biochemistry 1988;27:8063-8068.
27. Levitt MCC. Structural patterns in globular proteins. Nature 1976;261:552-558.
28. Lu X, Li L, Wu R, Feng X, Li Z, Yang H, Wang C, Guo H, Galkin A, Herzberg O, Mariano PS, Martin BM, Dunaway-Mariano D. Kinetic Analysis of Pseudomonas aeruginosa arginine deiminase mutants and alternate substrates provides insight into structural determinants of function. Biochemistry 2006;45:1162-1172.
29. Humm A, Fritsche E, Steinbacher S, Huber R. Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis. EMBO J 1997;16:3373-3385.
30. Fritsche E, Humm A, Huber R. Substrate binding and catalysis by L-arginine:glycine amidinotransferase: a mutagenesis and crystallographic study. Eur J Biochem 1997;247:483-490.
31. 2+-induced activation of human PAD4. Nat Struct Mo; Biol 2004;11:777-783.